Related Experiment Video
Updated: Jun 12, 2025

Differentiated Mouse Adipocytes in Primary Culture: A Model of Insulin Resistance
Published on: February 17, 2023
Insulin Resistance, Obesity, and Lipotoxicity
Dilek Yazıcı1, Selin Çakmak Demir2, Havva Sezer2
1Koç University Medical School, Section of Endocrinology and Metabolism, Koç University Hospital, Topkapi, Istanbul, Turkey. dyazici@ku.edu.tr.
Abstract:
Lipotoxicity, originally used to describe the destructive effects of excess fat accumulation on glucose metabolism, causes functional impairments in several metabolic pathways, both in adipose tissue and peripheral organs, like liver, heart, pancreas, and muscle. Ectopic lipid accumulation in the kidneys, liver, and heart has important clinical counterparts like diabetic nephropathy in type 2 diabetes mellitus, obesity-related glomerulopathy, nonalcoholic fatty liver disease, and cardiomyopathy. Insulin resistance due to lipotoxicity indirectly lead to reproductive system disorders, like polycystic ovary syndrome. Lipotoxicity has roles in insulin resistance and pancreatic beta-cell dysfunction. Increased circulating levels of lipids and the metabolic alterations in fatty acid utilization and intracellular signaling have been related to insulin resistance in muscle and liver. Different pathways, like novel protein kinase c pathways and the JNK-1 pathway, are involved as the mechanisms of how lipotoxicity leads to insulin resistance in nonadipose tissue organs, such as liver and muscle. Mitochondrial dysfunction plays a role in the pathogenesis of insulin resistance. Endoplasmic reticulum stress, through mainly increased oxidative stress, also plays an important role in the etiology of insulin resistance, especially seen in non-alcoholic fatty liver disease. Visceral adiposity and insulin resistance both increase the cardiometabolic risk, and lipotoxicity seems to play a crucial role in the pathophysiology of these associations.
Insights
Lipotoxicity, or excess fat accumulation, impairs metabolic pathways and causes organ dysfunction. This condition is a key factor in insulin resistance and increased cardiometabolic risk.
Area of Science:
- Metabolic and Cardiovascular Science
- Endocrinology
- Pathophysiology
Background:
- Lipotoxicity, characterized by excess fat accumulation, disrupts glucose metabolism and causes functional impairments in adipose tissue and peripheral organs including the liver, heart, pancreas, and muscle.
- Ectopic lipid accumulation in organs like the kidneys, liver, and heart is linked to clinical conditions such as diabetic nephropathy, nonalcoholic fatty liver disease, and cardiomyopathy.
- Lipotoxicity contributes to insulin resistance, pancreatic beta-cell dysfunction, and reproductive disorders like polycystic ovary syndrome.
Purpose of the Study:
- To elucidate the multifaceted role of lipotoxicity in metabolic dysfunction.
- To explore the mechanisms linking lipotoxicity to insulin resistance in non-adipose tissues.
- To understand the contribution of lipotoxicity to overall cardiometabolic risk.
Main Methods:
- Review of existing literature on lipotoxicity and its effects on metabolic pathways.
- Analysis of cellular and molecular mechanisms, including protein kinase C and JNK-1 pathways.
- Examination of the roles of mitochondrial dysfunction and endoplasmic reticulum stress in lipotoxicity-induced insulin resistance.
Main Results:
- Lipotoxicity impairs metabolic pathways in adipose tissue and peripheral organs, leading to ectopic lipid accumulation and associated diseases.
- Insulin resistance in muscle and liver is linked to increased circulating lipids and altered fatty acid metabolism.
- Specific pathways (PKC, JNK-1), mitochondrial dysfunction, and endoplasmic reticulum stress are implicated in lipotoxicity-driven insulin resistance.
Conclusions:
- Lipotoxicity is a central mechanism underlying insulin resistance and pancreatic beta-cell dysfunction.
- Ectopic lipid accumulation contributes to significant organ damage and clinical pathologies.
- Lipotoxicity plays a critical role in the increased cardiometabolic risk associated with visceral adiposity and insulin resistance.
Related Concept Videos
Obesity
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Insulin: The Receptor and Signaling Pathways
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Oral Hypoglycemic Agents: Biguanides and Glitazones
Cholesterol: Significance and Regulation
Considering cholesterol and...

